GLOW 50 [GHK-CU (30mg) / BPC-157 (10mg) / TB500 (10mg)]

About this formulation

GLOW 50 combines three peptides that appear together across tissue regeneration and dermatology research:

• GHK-Cu (30mg) — copper-binding tripeptide investigated for collagen synthesis and gene expression
• BPC-157 (10mg) — gastric juice-derived pentadecapeptide investigated for angiogenesis and inflammation modulation
• TB-500 (10mg) — Thymosin Beta-4 fragment investigated for actin regulation and cell migration

Mechanism in Research Literature

The three peptides act through distinct but overlapping pathways:

• GHK-Cu: copper delivery, collagen synthesis stimulation, gene expression modulation
• BPC-157: angiogenesis, GH-receptor expression upregulation, inflammatory cytokine modulation
• TB-500: actin sequestration, stem and endothelial cell migration, vascular remodeling
• Combined: research-relevant coverage of collagen synthesis (GHK-Cu), inflammation control (BPC-157), and cellular migration (TB-500)

Research Context

The component peptides appear together in literature exploring:

• Dermal regeneration and skin remodeling
• Connective tissue repair
• Wound healing dynamics
• Hair follicle biology

Related Research Peptides

GLOW 50 sits alongside the related KLOW formulation (which adds KPV) and the standalone GHK-Cu, BPC-157, and TB-500 product pages.

For research and educational use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.